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The formation of the coronary vessel system is vital for heart development, an essential step of which is the establishment of a capillary
plexus that displays a density gradient across the myocardial wall, being higher on the epicardial than the endocardial side. This gradient in
capillary plexus formation develops concurrently with transmural gradients of myocardium-derived growth factors, including FGFs. To test
the role of the FGF expression gradient in patterning the nascent capillary plexus, an ectopic FGF-over-expressing site was created in the
ventricular myocardial wall in the quail embryo via retroviral infection from E2–2.5, thus abolishing the transmural gradient of FGFs. In FGF
virus-infected regions of the ventricular myocardium, the capillary density across the transmural axis shifted away from that in control hearts
at E7. This FGF-induced change in vessel patterning was more profound at E12, with the middle zone becoming the most vascularized. An
up-regulation of FGFR-1 and VEGFR-2 in epicardial and subepicardial cells adjacent to FGF virus-infected myocardium was also detected,
indicating a paracrine effect on induction of vascular signaling components in coronary precursors. These results suggest that correct
transmural patterning of coronary vessels requires the correct transmural expression of FGF and, therefore, FGF may act as a template for
coronary vessel patterning.
D 2005 Elsevier Inc. All rights reserved.
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An adequate blood supply for the working myocardium
is essential for heart function. Before the coronary circu-
latory system is formed, the myocardial wall is avascular
and believed to be nourished by diffusion through the
endocardium, via trabecular channels that markedly increase
endocardial surface area (Rychter and Osta´dal, 1971;
Rychterova, 1971). The endothelial, vascular smooth
muscle and other mural cells of the coronary vasculature
are derived from the epicardium (Dettman et al., 1998; Li et
al., 2002; Mikawa and Fischman, 1992; Mikawa and
Gourdie, 1996; Pe´rez-Pomares et al., 1998). These precur-
sors begin to contact the heart tube among the proepicar-0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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Queensland, Brisbane, QLD, 4072, Australia.dium at around HH17. Epicardial cells destined to
contribute to intramural coronary vessels undergo an
epithelial–mesenchyme transformation, delaminate and
invade the myocardium to form a capillary plexus that is
formed by a vasculogenic process (Mikawa and Fischman,
1992). This capillary network is then remodeled into the
mature, intramural coronary blood vessels (for a review, see
Bernanke and Velkey (2002)), eventually forming a closed
coronary vascular system at HH32 in the quail (Vrancken
Peeters et al., 1997).
As the myocardium develops, the nascent coronary
capillary plexus displays a density gradient across the
transmural axis of the myocardial wall, being higher on
the outer, epicardial side than the inner, endocardial side
(Tomanek et al., 1999b). The formation of the capillary
plexus in the myocardium is an essential stage in the
formation of the coronary vasculature. However, it is
unknown what patterns the capillary plexus gradient across
the transmural axis of the myocardium.279 (2005) 378–390
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concomitant with the formation of the coronary capillary
plexus, there are also gradients of growth factors implicated
in blood vessel formation that also show higher expression
in the outer, epicardial, than the inner, endocardial, side of
the myocardium. These include FGF1 and FGF2 in the
chick embryo (Consigli and Joseph-Silverstein, 1991;
Pennisi et al., 2003) and FGF2 in the bovine heart (Kardami
and Fandrich, 1989). Moreover, VEGF, one of the most
potent vasculogenic and angiogenic growth factors (for
review, see Neufeld et al. (1999)) is expressed with a similar
transmural gradient in the rodent embryo heart (Tomanek et
al., 1999b). These observations have lead to a hypothesis
that a gradient of hypoxia is important in patterning the
capillary plexus along the transmural axis of the myocar-
dium (Tomanek et al., 1999a,b). Importantly, the expression
of all of these factors has not been described in detail in
relation to coronary vessel patterning in a single species.
FGFs and VEGF have been shown to act directly on
endothelial cells, affecting different processes involved in
vessel induction and formation, including differentiation,
proliferation and cell migration (for reviews, see (Neufeld et
al., 1999; Presta et al., 2000)). In addition, there is evidence
that FGFs can act upstream of the VEGF signaling pathway,
up-regulating expression of VEGF (Seghezzi et al., 1998;
Tille et al., 2001) and VEGFR-2 (Pepper and Mandriota,
1998), further supporting a possible role for FGFs in the
formation or patterning of vascular networks.
It is, therefore, clear that there is communication
between the FGF and VEGF signaling pathways, at least
in vessel development, although the underlying mecha-
nisms are not well understood. Moreover, less is known
about the interaction between these two signaling cas-
cades in heart development and how this may relate to
coronary vessel development. Our previous work has
demonstrated that ectopic over-expression of FGFs in
coronary vascular cell precursors promotes the formation
and branching of coronary blood vessels in an autocrine
manner (Hyer et al., 1999). Thus, we hypothesized that
the gradient of FGF across the transmural axis of the
myocardium acts as a template for the formation of the
coronary capillary plexus.
We tested this hypothesis by examining the relation-
ship between the transmural gradient of growth factor
expression and the patterning of the nascent, intramural
coronary vessels in the quail embryo. We describe that
between E7 and E14 in wild-type quail embryos there is
a gradient of myocardial expression of FGF1, FGF2 and
VEGF that is higher adjacent to the epicardium than
endocardium. Concordant with this, the density of the
intramural vasculature is higher in the outer, epicardial
region of the myocardium. We then over-expressed FGF
ligand to alter the transmural gradient of FGF across the
myocardium wall. The resultant embryos displayed a shift
in the gradient of vessel density across the myocardial
wall with the change in FGF expression. Furthermore,FGFR-1 and VEGFR-2 were up-regulated in epicardial
and subepicardial cells adjacent to myocytes over-
expressing FGF, alluding to a mechanism by which
myocyte-derived FGFs may act to produce a vessel-
promoting effect in a paracrine manner. Therefore, we
conclude that patterning of the intramural coronary
vessels requires the correct expression gradient of FGFs
across the transmural axis of the myocardium.Methods and materials
Embryonic manipulations
Fertile quail eggs were purchased from CBT Farms
(Chestertown, Maryland) and incubated at 388C under
humidified conditions. Embryos were staged according to
the number of days of incubation or by the staging system of
Hamburger and Hamilton (Hamburger and Hamilton, 1951).
Immunohistochemistry
Immunohistochemistry was performed using standard
techniques as previously described (Pennisi et al., 2003).
The following primary antibodies were used for immuno-
staining histological sections: anti-FGF1 antibody (cat. # sc-
1884, Santa Cruz Biotechnology Inc., CA, USA), anti-FGF2
antibody (cat. # sc-79, Santa Cruz Biotechnology Inc., CA,
USA), anti-FGFR-1 (Flg) antibody (cat. # sc-15, Santa Cruz
Biotechnology Inc., CA, USA), QH1 antibody (Develop-
mental Studies Hybridoma Bank, The University of Iowa,
Department of Biological Sciences, Iowa City, IA 52242),
anti-VEGF antibody (cat. # sc-152, Santa Cruz Biotechno-
logy Inc., CA, USA) and anti-VEGFR-2 (cat. # sc-505,
Santa Cruz Biotechnology Inc., CA, USA).
Injection of retroviral constructs
High titer preparations (107–108 plaque forming units/
ml) of replication-incompetent retroviruses were prepared
and pressure-injected in ovo into the pericardial space of
HH11-13 embryos to infect myocardial cells as previ-
ously described (Mikawa and Fischman, 1992). The
retroviruses employed in this study have been published
previously: CXL (expressing h-galactosidase), SNFGF1lZ
(expressing FGF1 fused with a secretion signal and h-
galactosidase from a di-cistronic mRNA) and SNFGF4lZ
(expressing FGF4 with an authentic secretion signal and
h-galactosidase from a di-cistronic mRNA). The bio-
logical activity and paracrine effects of FGFs expressed
from these viral vectors in avian embryos have been
reported elsewhere (Hyer et al., 1999, 1998, 2003; Itoh et
al., 1996; Mikawa et al., 1991; Mima et al., 1995a,b;
Sugi et al., 2003). Hearts were dissected for analysis at
various stages of development (embryonic days (E) 7,
E10 and E12) in phosphate buffered saline (PBS), fixed
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and stained with X-gal at 378C overnight. After
numerous washes in PBS and whole-mount photography,
selected samples were dehydrated in an ethanol series,
cleared in CitriSolv (Fisher Scientific, USA) and embed-
ded in paraffin. Serial, 7 Am, transverse sections were cut
and mounted on Superfrost slides (VWR, USA).
Data documentation and analysis
Images were captured using either a Digital Photo
Camera (DKC-5000, Sony) or a Spot RT Slider (2.3.1,
Diagnostic Instruments Inc., USA) using Adobe Photoshop
(version 7.0, Adobe Systems Inc.) or Spot (version 3.2.6
Diagnostic Instruments Inc, USA) software, respectively.
Images were adjusted for color levels, brightness and
contrast, and figures were then compiled, using Adobe
Photoshop software (version 7.0, Adobe Systems Inc.).
Quantification of vessel density
Analyses were conducted on the left and right
ventricular free wall, at approximately the midpoint of
the ventricle along the apex-base axis. The compact
myocardium was defined as the region between the
epicardium and the lower limit of the trabeculae. For the
purposes of transmural quantification, the myocardium
was divided into three regions along the transmural axis,
the inner, middle and outer myocardial wall (see Fig. 2).
The radial borders for regions of analyses (for wild-type
and virus-infected regions) were lines drawn at right
angles to the outer curvature of the myocardium. All
quantification was conducted using Adobe Photoshop
(version 7.0, Adobe Systems Inc.). This included the
determination of area in pixels (converting to Am2 where
appropriate). Quantification of vessel density after QH1
immunostaining on histological sections was performed
on digitally recorded images of 20 magnification. For
the purposes of objectivity in determining the intensity
and area of DAB immunostaining, digital images were
adjusted in Adobe Photoshop thus; to avoid confounding
background from X-Gal staining, the blue (R 20, G 80, B
120) was lightened by 85% (bReplace ColorQ function).
Brightness and contrast were increased by 30% each.
Images were then converted to a binary mode by
converting pixels to either black or white (bThresholdQ
function), where all pixels above the threshold (set at 200
here) in luminance were converted to white and all those
below were converted to black. The areas of selected
regions, either black or white were calculated using the
histogram of the levels of the pixels (in the bThresholdQ
dialogue box). The area of immunostaining (black pixels)
was then converted to Am2. Three regions of both the
right and left ventricles from different wild-type (WT)
hearts were quantified at E7, E10 and E12. Standard
deviation from the mean (SDM) was calculated forgroups of quantitative data. Statistical significance was
determined using a Student’s two-tailed t test.Results
Growth factor expression and capillary patterning across
the myocardial wall
In the first set of experiments, developmental changes
in the expression pattern of FGF, and VEGF, as well as
coronary vessel formation across the transmural axis of
the developing myocardium, were examined in the quail
embryo. Our analysis focused on developmental stages
between embryonic day 7 (E7) and E14, when the
capillary plexus is forming and being remodeled, and
until the time the coronary vascular system connects to
the systemic circulatory system (Rychter and Osta´dal,
1971; Rychterova, 1971; Vrancken Peeters et al., 1997).
FGF1, FGF2, VEGF and endothelial cells of the coronary
vasculature were immunolocalized in the ventricular
myocardium.
At E7, the formation of nascent coronary capillary
plexus was detectable in the compact myocardium (Figs.
1A, B). By E10, more and larger vessels formed in the
outermost region (adjacent to the epicardium) than the
inner region (adjacent to the endocardium) of the
compact myocardium (Figs. 1F, G). This gradient across
the transmural axis of the compact myocardium became
more prominent at E12 (Figs. 1K, L) and persisted at
E14 (Figs. 1P, Q). At E7, FGF1, FGF2 and VEGF,
proteins were detected throughout the myocardium and
epicardium (Figs. 1C–E). Stronger signals, particularly for
FGF2 and VEGF, were detected in the outermost region
of the compact myocardium compared to the inner,
subendocardial region. Similarly, at E10 and E12, this
pattern of growth factor expression was maintained in the
compact myocardium (Figs. 1H–J, M–O). At E14, the
transmural gradient of FGF1, FGF2 and VEGF expres-
sion persisted and the portion of the myocardium with
higher protein levels became a more restricted, narrow
region subjacent to the epicardium (Figs. 1R–T). At all
stages examined, we observed FGF1 and/or FGF2 in the
cytoplasm as well as associated with the extracellular
space. We also found strong perinucleolar immunostain-
ing for FGF1 at E7 (Figs. 1C, CV) and cytoplasmic
staining in a subpopulation of the trabecular myocardium
at E10 (Fig. 1H). Despite the dynamic expression pattern,
the strong immunostaining of FGF1 was consistently
detected at the outer myocardium between E7–E14.
These data show that a gradient of FGF1, FGF2 and
VEGF expression across the transmural axis of the
myocardium is established during capillary patterning in
the embryonic quail heart, consistent with studies on
FGF1 and FGF2 in the chick heart (Consigli and Joseph-
Silverstein, 1991; Pennisi et al., 2003), FGF2 in the
Fig. 1. There is a transmural gradient across the myocardial wall of vessel density and vessel-promoting growth factors in the developing avian heart. (A–E) E7;
(F–J) E10; (K–O) E12; (P–T) E14 (scale bars, 50 Am). Panels CV–SV are higher magnification views of the outer myocardium (arrows) in panels C–S (scale bar,
5 Am). Immunohistochemical detection of vascular endothelia with the QH1 antibody (B, G, L and Q) reveals the nascent capillary network in the compact
myocardium with a greater number of vessels in the outermost region. This difference becomes more prominent at E12 and E14. Concomitant with the
development of the coronary capillary plexus is expression of known vessel-promoting factors, FGF1 (C, H, M and R), FGF2 (D, I, N and S) and VEGF (E, J,
O and T), where a higher level of expression is in the outermost region of the myocardium, subjacent to the epicardium (indicated by arrows). This transmural
pattern is evident from E7 to E14. No signal was detected in non-immune serum controls (A, F, K and P). Open arrowheads, nuclear and/or perinucleolar
localization of FGF1; asterisks, zones exhibiting higher immunostaining of cytoplasmic and/or extracellular FGF1 and FGF2.
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the rodent heart (Tomanek et al., 1999b).
Vessel density gradient across the transmural axis of the
myocardium
To quantify the above visual inspection of a transmural
gradient in coronary plexus formation, vessel density was
measured individually at an inner, middle and outer zone of
the compact myocardium, using morphometric analyses
(Fig. 2). Vessel density in each of these sub-regions was
estimated using two parameters, the number of vessels/Am2
and vessel area per region (expressed as a percentage). At
E7, a stage shortly after angioblasts invade the myocardium,
both the right and left ventricles were clearly trabeculate
(Figs. 2B, C). Also evident at this stage was the thin nature
of the compact myocardium relative to later stages. The
mean values for the number of vessels/Am2 at the inner,
middle and outer regions of the right ventricle were 1.2 
105, 3.3  105 and 2.0  105 (SDM 4.5  106, 1.1 105 and 9.0  106), respectively (Fig. 2H). For the left
ventricle, the values were 1.7  105 (inner), 2.2  105
(middle) and 1.9  105 (outer) (SDM 4.7  106, 7.0 
106 and 7.9  106, respectively). The mean values for
vessel area at the inner, middle and outer regions for the
right ventricle were 14.5% (F4.7%), 30.5% (F13.2%) and
39.3% (F22%), respectively (Fig. 2I). Similarly, in the left
ventricle, the vessel density for the inner, middle and outer
regions were 26.9% (F9.2%), 33.9% (F7.6%) and 42.3%
(F14.8%), respectively. Taken together, the data show that
capillary plexus formation is most active in the outermost
region of the myocardium at this developmental stage.
At E10 (Figs. 2D, E), an intermediate stage in coronary
plexus formation, the trabeculae were still conspicuous but
somewhat diminished compared to E7. The compact myo-
cardium at this stage was thicker than at E7. The mean values
of the number of vessels/Am2 at the inner, middle and outer
regions of the right ventricle were 2.9 105, 3.5 105 and
4.5  105 (SDM 1.1  105, 1.0  105 and 1.7  105),
respectively (Fig. 2H). For the left ventricle, the values were
Fig. 2. Quantification of the transmural gradient of vessel density in wild-type quail hearts at E7, E10 and E12. (A) Diagrammatic representation of the regions
of the myocardial compact layer analyzed for vessel density quantification for the left ventricle (LV) and right ventricle (RV) and the subdivision of the
myocardial free wall into an bouterQ (o), bmiddleQ (m) and binnerQ (i) zone for quantification of vessel density in this study (see Methods and materials).
Examples of QH1 immunostaining are shown for the right and left ventricle at E7 (B and C, respectively), at E10 (D and E, respectively) and E12 (F and G,
respectively). Summaries of the mean values for wild-type vessel densities in terms of number of vessels/Am2 (H) and vessel area as a percentage (I) are given
for the inner, middle and outer regions of the compact myocardium at E7, E10 and E12. The sub-regions of the compact myocardium are denoted by varying
shades of gray; lightest for binnerQ, medium for bmiddleQ and darkest for bouterQ. Asterisks denote a statistically significant difference ( P b 0.05) in vessel
density for a particular sub-region relative to the outermost (o) region of that particular ventricle at that developmental stage. Note that the transmural gradient
of vessel density becomes more pronounced as development proceeds, both in terms of number of vessels/Am2 and percentage vessel area. ep, epicardium; cm,
compact myocardium; tr, trabeculae; en, endocardium. The mean values for the wild-type controls are indicated. Error bars, standard deviation of the mean.
Scale bar, 100 Am.
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(outer) (SDM 8.0  106, 7.2  106 and 9.8  106,
respectively). The mean values of vessel areas at the inner,
middle and outer regions for the right ventricle were 20.3%(F15.2%), 23.5% (F12.5%) and 42% (F26%), respectively.
Similarly, in the left ventricle, the vessel areas at the inner,
middle and outer regions were measured as 19.3% (F9.6%),
19.5% (F6.7%) and 35.3% (F10.8%), respectively (Fig. 2I).
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was highest in the outer region both for the left and right
ventricles.
At E12, the trabeculae became much less conspicuous
and the coronary vessel network was more patterned,
including vessels exhibiting a larger lumen than at E7 and
E10, particularly in the left ventricle. Furthermore, the
outermost and innermost capillaries were oriented perpen-
dicular to the plane of section. The mean values of the
number of vessels/Am2 at the inner, middle and outer regions
of the right ventricle were 2.0  105, 2.2  105 and 4.5 
105 (SDM 4.3  106, 3.5  106 and 9.8  106),
respectively (Fig. 2H). For the left ventricle, the values were
2.5  105 (inner), 2.2  105 (middle) and 3.8  105
(outer) (SDM 4.1  106, 4.9  106 and 9.5  106,
respectively). The values for the inner, middle and outer
regions for the right ventricle at E12 were 12.2% (F4.2%),
9.7% (F5%) and 28% (F11.6%), respectively (Fig. 2I).
Similarly, in the left ventricle, the vessel density for the inner,
middle and outer regions were 7.7% (F3%), 9.3% (F2.4%)
and 26.6% (F6.4%), respectively. Thus, the transmural
gradient of vessel densities (the relative proportion of the
inner, middle and outer regions) was more pronounced at
E12 than at E7 and E10 in both the right and left ventricles.
Production and analysis of FGF virus-infected hearts
To test whether the gradient of FGF across the transmural
axis of the myocardium acts as a template for the formation ofFig. 3. Experimental protocol used for retroviral over-expression of FGFs in the m
replication-incompetent retroviral vectors used in the study; CXL (expressing Lac
LacZ from a di-cistronic mRNA) and SNFGF4lZ (expressing FGF4 encoding an a
example of retroviral injection into the pericardial cavity of a stage HH11 embryo. E
representative examples of hearts dissected and X-Gal-stained at E7 (C–E), E10
infection were observed in FGF4 virus-injected hearts relative to FGF1 virus-injethe coronary capillary plexus, the endogenous FGF gradient
was abolished by expressing exogenous FGF locally in the
ventricular myocardium through infection with replication-
deficient retroviral vectors. The vectors used expressed either
FGF1 (SNFGF1lZ) or FGF4 (SNFGF4lZ) and h-galactosi-
dase (h-gal) from di-cistronic mRNA or h-gal alone (CXL)
(Fig. 3A). The FGF4-expressing retroviral vector was
included as control of as other studies have demonstrated a
response by endothelial cells to FGF4 expression in a
paracrine manner (Dell’Era et al., 2001). Viral particles were
injected into the pericardial cavity of stage HH11–13 (E2–
2.5) quail embryos in ovo before proepicardium formation
was evident, thus avoiding epicardial infection (Fig. 3B).
Hearts were harvested at E7, E10 and E12 and survival was
assessed by the presence or absence of a beating heart. The
survivability of embryos that received FGF1 virus injection
compared with CXL-injected hearts was 16/35 (46%) and
13/19 (68%) at E7, respectively; 11/32 (34%) and 11/20
(55%) at E10, respectively and 11/50 (22%) and 11/23 (48%)
at E12, respectively. The survival rates of FGF4 virus-
injected were lower than those infected with FGF1 virus, with
19/37 (51%) at E7, 4/29 (14%) at E10 and 0/23 (0%) at E12.
Regions containing virus-infected myocytes were identified
by whole-mount X-Gal staining of hearts (Figs. 3C–J)
followed by histological sectioning. Sections displaying X-
Gal-positive areas were then processed for QH1 immunohis-
tochemistry and vessel density analysis. For vessel density
analyses, FGF1 and FGF4 virus-injected samples were
grouped together for comparison to control samples.yocardium of embryonic quail hearts. A, diagrammatic representation of the
Z), SNFGF1lZ (expressing FGF1 fused to a secretion signal (asterisk) and
uthentic secretion signal (asterisk) and LacZ from a di-cistronic mRNA). B,
xamples of whole-mount, X-Gal-stained hearts. Ventral and dorsal views of
(F–H) and E12 (I, J) are shown. Note that at E7 and E10, lower levels of
cted hearts.
D.J. Pennisi, T. Mikawa / Developmental Biology 279 (2005) 378–390384Changes in the transmural gradient of vessel density in
FGF virus-infected hearts
Vessel densities were examined in regions of the
myocardium where infection with FGF viruses was evident
across the myocardial wall or more prominently in the inner
and middle zones relative to the outer zone. At E7, FGF
virus-infected hearts exhibited an overall increase in the
number of vessels in all the regions of the compact
myocardium compared to those infected with control CXL
virus (Figs. 4A–C, F, G). Both control and the majority of
FGF virus-infected regions showed a similar transmural
pattern in the number of vessels/Am2 between the inner,
middle and outer regions (i.e., the transmural gradient) of
the compact myocardium at this stage. Both test and control
hearts developed a higher number of vessels/Am2 at the
middle region than the outer and inner regions (Fig. 4F).
While no significant change was detected in the gradient of
vessel density across the myocardium in terms of number ofFig. 4. Alteration of the gradient of vessel density across the myocardial transmura
the right ventricle of samples that have been X-Gal stained and immunostained f
quantitative analyses. (B) CXL-infected sample at E7. (C) FGF virus-infected samp
E12. Vessel densities at E7 for the inner, middle and outer regions of the compac
vessels/Am2 (F) and percentage vessel area (G). Likewise, the density values obta
vessel area (I). Values for the right and left ventricles are indicated. Note the overa
and outer zones–of the compact myocardium in most FGF virus-infected samples a
and E are denoted by asterisks in panels F–G and H–I, respectively. The sub-re
lightest for binnerQ, medium for bmiddleQ and darkest for bouterQ. RV, right ventric
wild-type controls are included for ease of comparison and are indicated (WT). Evessels/Am2, more than half the FGF virus-infected hearts
exhibited a shift in vessel density gradient in vessel area
away from the outermost region being the highest, having
higher values for the inner or middle sub-region rather than
the outer (Fig. 4G).
At E12, FGF virus-infected hearts displayed more
pronounced changes both in the relative proportions of
the number and area of vessels across the compact
myocardium (Figs. 4D, E, H, I). Four of seven samples
exhibited a strong shift and one a mild shift in vessel
numbers, with the highest value in the middle region
(Fig. 4H). In addition, up to a three-fold increase in the
average vessel size in the inner, middle and outer zones
of the myocardium was detected at all FGF virus-infected
regions. Importantly, the majority also showed a signifi-
cant increase in vessel area in the inner and middle
regions relative to that in the outer region (Fig. 4I). Thus,
the data suggest that a local expression of exogenous
FGF gives rise to a shift in the gradient of vessel densityl axis in FGF virus-infected samples at E7 and E12. Examples are shown of
or QH1. (A) List of the FGF expressing virus-injected samples used in the
le at E7. (D) CXL-infected sample at E12. (E) FGF virus-infected sample at
t myocardium in FGF virus-infected samples were expressed as number of
ined at E12 were expressed as number of vessels/Am2 (H) and percentage
ll increase in the number and area of vessels in all regions–the inner, middle
t E7 and E12. The quantitative values for representative samples in panels C
gions of the compact myocardium are denoted by varying shades of gray;
le; LV, left ventricle; i, inner; m, middle; o, outer. The mean values for the
rror bars, standard deviation of the mean. Scale bar, 100 Am.
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the compact myocardium at E12.
The above morphometric analyses revealed that in
regions of the right ventricular myocardium infected with
FGF1- and FGF4 virus, there was an overall increase in the
number and volume of vessels in all compact myocardial
regions (summarized in Fig. 5). Importantly, a change in the
capillary density across the transmural axis was also evident
with a shift in vessel distribution away from gradient ob-
served in control hearts. These effects were more pronoun-
ced at E12 than at E7.
Subepicardial up-regulation of FGFR-1 and VEGFR-2 in
response to myocardial over-expression of FGFs
FGF is a regulator of the expression of VEGF signaling
components, including VEGF receptor expression in endo-
thelial cells (Pepper and Mandriota, 1998). A positive feed-
back effect of FGFs on FGF receptor expression is alsoFig. 5. Summary of the changes in the gradient of vessel density across the my
statistically significant difference ( P b 0.05) in vessel density in FGF expressing
control (Fig. 2). The sub-regions of the compact myocardium are denoted by varyi
bouterQ. RV, right ventricle; i, inner; m, middle; o, outer. The mean values for the
deviation of the mean.reported (Estival et al., 1996; Saito et al., 1991). Although a
gradient of FGFR-1 expression across the transmural axis of
the myocardium has been reported by us and others
(Patstone et al., 1993; Pennisi et al., 2003), we have focused
our attention on the possible paracrine effect on myocar-
dium-derived FGFs on the epicardial-derived coronary
precursors. Thus, we hypothesized that a change in VEGFR
and FGFR expression in coronary precursor and vasculature
may be associated with a shift of vessel patterning induced
by an altered FGF gradient across the myocardium. There-
fore, to test this possibility, the expression of VEGFR-2 and
FGFR-1 in coronary vasculature was examined in FGF
virus-infected and control hearts using immunohistoche-
mistry. While no significant change in FGFR-1 and
VEGFR-2 immunosignals in the myocardium between
control CXL virus- and FGF virus-infected hearts was
observed, more FGFR-1-positive cells were detected among
epicardial cells and those in the subepicardial space adjacent
to FGF virus-infected myocardium compared to controls atocardial transmural axis in FGF virus-infected hearts. Asterisks denote a
virus-infected sub-regions (Fig. 4) relative to the corresponding wild-type
ng shades of gray; lightest for binnerQ, medium for bmiddleQ and darkest for
wild-type controls are included for ease of comparison. Error bars, standard
Fig. 6. FGF Receptor-1 and VEGFR Receptor-2 expression in subepicardial cells of control virus- and FGF virus-infected hearts. (A–H) Immunostaining for
FGFR-1; (I–P) immunostaining for VEGFR-2. Representative examples are shown for control virus-infected samples at E7 (A and I) and E10 (E and M) and
FGF virus-infected samples at E7 (C and K) and E10 (G and O). Higher magnification views of the boxed areas in panels A, C, E, G, I, K, M and O are shown
in panels B, D, F, H, J, L, N and P, respectively. FGFR-1 and VEGFR-2 are up-regulated in subepicardial cells (indicated by arrows) in proximity to FGF virus-
infected myocardium relative to control virus-infected samples. Note that immunohistochemistry was performed in a way that ensured identical staining times
between test and control samples and before high levels of expression were detected in surrounding regions (such as the myocardium) or the immunostaining
became over-stained. Scale bar, 50 Am.
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appeared more pronounced in epicardial and subepicardial
cells at E10 adjacent to FGF virus-infected than CXL virus-
infected myocardium (Figs. 6E–H). By contrast, there was
no detectable difference in the intensity or number of
VEGFR-2-immunoreactive epicardial or subepicardial cells
in regions adjacent to FGF virus-infected myocardium at E7
(Figs. 6I–L). At E10, however, there were an increased
number of VEGFR-2-immunoreactive subepicardial cells in
regions adjacent to FGF virus-infected myocardium (Figs.
6M–P). These data show that epicardial and subepicardial
cells can respond to myocardium-derived FGF, indicating a
possible mechanism by which paracrine signals may induce
vessel formation among coronary precursors.Discussion
The formation of a functional coronary vasculature is
essential for proper heart development. An essential
component of this is establishing an intramural capillary
plexus that is remodeled into a functional coronary
vasculature. It remains to be determined, however, what
mechanism(s) patterns this capillary plexus (Galoforo et al.,
1996; Kim et al., 2002; Seghezzi et al., 1998; Tille et al.,
2001; Tomanek et al., 1999a,b; Zheng et al., 2001). In this
study, we have shown that a myocardial FGF gradient plays
a crucial role in the regulation of the vessel density gradient
that is higher in the outermost region of the compact
myocardium.
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compact myocardium has revealed a progressive patterning
process of the coronary capillary plexus across the trans-
mural axis of the ventricular myocardium during the second
week of quail embryo development. Our data are consistent
with a transmural gradient of vessel formation found in rat
embryonic hearts (Tomanek et al., 1996), suggesting a
common patterning process in embryonic hearts both of
birds and mammals. Together with previous studies in chick
and rat embryos (Consigli and Joseph-Silverstein, 1991;
Kardami and Fandrich, 1989; Pennisi et al., 2003; Tomanek
et al., 1999b), our immunohistochemical data show that the
gradient of the expression of vessel-promoting growth
factors, FGFs and VEGF, occurs concomitantly with the
development of the transmural gradient of vessel density
across species.
FGFs have long been implicated in vessel development
and can influence the proliferation, migration and differ-
entiation of vascular cells (for review, see Detillieux et al.
(2003)). In the bird, ectopic FGF2 can induce QH1
expression among somitic mesoderm indicating angioblast
induction, as well as inducing vessel formation in the quail
embryo (Cox and Poole, 2000). The role of FGFs in
vascular development is further complicated by the fact that
FGF2 has been shown to up-regulate VEGF and VEGFR-2
(Pepper and Mandriota, 1998; Seghezzi et al., 1998; Tille et
al., 2001). Therefore, FGFs can promote vessel growth by
acting directly on endothelial cells (Cummins, 1993; Risau
and Flamme, 1995) and indirectly through VEGF signaling.
VEGF, however, has not been shown to up-regulate FGFs or
their high affinity receptors. Although there is evidence for a
communication between the FGF and VEGF pathways, they
may also act independently and, therefore, be controlled in
different ways.
Experimental evidence on the heart has shown that FGF2
is involved in arteriolar formation and VEGF and FGF2
together appear to modulate coronary capillary angiogenesis
(Tomanek et al., 2001). FGF1 has been suggested to act on
coronary endothelial cells in a paracrine manner (Engel-
mann et al., 1993). In addition, our previous work has
demonstrated that over-expression of FGFs in coronary
vascular cell precursors promotes the formation and
branching of coronary blood vessels in an autocrine manner
(Hyer et al., 1999). These data, with the transmural gradient
of FGFs expression coincident with coronary vessel
formation (Consigli and Joseph-Silverstein, 1991; Kardami
and Fandrich, 1989; Pennisi et al., 2003), suggested a role of
FGFs in coronary patterning (Tomanek et al., 1996). Direct
experimental evidence on modulating the transmural gra-
dient of FGF expression, however, has been lacking.
Transgenic mice over-expressing FGF1 in the myocardium
displayed an increase in the density of coronary arteries,
particularly arterioles, although early stages of coronary
vessel formation were not examined (Fernandez et al.,
2000). In these mice, the endogenous transmural gradient of
FGF1 was further enhanced, not abolished, by transgenesis.To overcome the technical difficulties sometimes
encountered in some transgenic and knock-out mice,
replication-incompetent retroviral vectors were used in this
study to over-express FGF ligands locally in the myocar-
dium in the quail embryo, thus abolishing the endogenous
transmural gradient of FGF. This allowed us to experimen-
tally address the relationship between the observed gradient
of myocardium-derived FGF and the gradient of the
developing, intramural vasculature in mosaic transgenic
embryos, thus avoiding potential lethality with whole-
embryo transgenesis. Our data show that altering the
gradient of FGF expression levels across the transmural
axis of the myocardial wall results in a concomitant shift in
the gradient of vessel density. Thus, the data we present here
provide evidence that the pattern of FGF expression in the
myocardium may act as a template for the patterning of the
coronary capillary plexus. This study has also shown that
altering the transmural gradient of FGF expression across
the myocardium not only shifts the gradient of capillary
density, but also increases vascularization in all zones of the
myocardium at the stages examined. This is consistent with
the known effect of FGFs on promoting vascular develop-
ment (Cummins, 1993; Risau and Flamme, 1995).
What remains unclear is what controls FGF expression
in the developing myocardium and how this relates,
specifically, to coronary vessel patterning. Numerous
stimuli could potentially contribute to induction of FGF
expression in the developing myocardium and thus
contribute to the patterning of the coronary vasculature.
These include intrinsic, genetic and epigenetic factors,
paracrine signals from other tissues or biomechanical and
physical stimuli. Our previous studies have shown that
the transmural gradient of FGF (and FGFR-1) expression
in the developing myocardium is maintained in the
absence of the epicardium, albeit at reduced levels
(Pennisi et al., 2003). This indicated that paracrine
signaling alone between adjacent tissues could not
account for the gradient of growth factor expression
across the transmural axis of the myocardium. Bio-
physical stimuli could include hypoxia (Tomanek et al.,
1999a,b; Yue and Tomanek, 1999), hypoglycemia (Galo-
foro et al., 1996) and stretch or pressure load (Kim et al.,
2002; Zheng et al., 2001), all of which can up-regulate the
expression of factors that promote vascular formation.
Although shear stress has been shown to up-regulate FGFs
in several cell types (Malek et al., 1993; Singh et al., 1998),
it seems unlikely that cardiomyocytes would be directly
subject to shear stress resulting from laminar flow.
Hypoxia has also been hypothesized to be a factor in
patterning the intramural capillary network (Tomanek et al.,
1999a,b; Yue and Tomanek, 1999). The developing ven-
tricular myocardium is hypoxic (Lee et al., 2001) and it is
believed that the immature, avascular myocardium is
nourished by diffusion from the lumen of the heart
chambers and, therefore, the outermost regions of the
compact myocardium would be most hypoxic. Furthermore,
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and ARNT) are indispensable for vascular development
(Adelman et al., 2000; Maltepe et al., 1997). It is well
established that hypoxia induces VEGF expression (Neufeld
et al., 1999) and that a transmural gradient of VEGF
expression has been reported in the embryonic rat heart
(Tomanek et al., 1999b). The responsiveness of FGF
expression to hypoxia, however, is less well established.
FGF1 and FGF2 have been shown to be up-regulated under
hypoxic conditions in cultured carcinoma cells (Lee and
Corry, 1999), glial cells (Ganat et al., 2002) and mono-
nuclear phagocytes (Kuwabara et al., 1995), and, moreover,
that FGF2 can enhance vascularization responsiveness
under hypoxic conditions (Li et al., 2003). Conversely,
some studies failed to find an up-regulation of FGFs under
hypoxic conditions in retinal cells (Shima et al., 1995) and
in an avascular, in vivo tumor model (Fang et al., 2001).
FGFs are involved in other processes in the developing
heart: FGFs are important for cardiac myocyte proliferation,
particularly at earlier stages (Mima et al., 1995b) and FGF2
has been implicated in cardiac hypertrophy in the adult
myocardium (reviewed by Detillieux et al. (2003)). Cardiac
myocytes are capable of producing FGF2 in response to
mechanical load (Kaye et al., 1996b) and FGF is up-
regulated in the adult heart by ischemia or hemodynamic
burden (Schneider et al., 1992). Furthermore, FGFs in the
cytoplasmic of myocytes can be released after stress or
injury (Clarke et al., 1993, 1995; Kardami et al., 1991; Kaye
et al., 1996a). It is, therefore, difficult to separate myocardial
growth and response to physical stimuli and factors that may
affect coronary vascularization. Experimentally pressure-
overload hearts resulting in hypertrophy does not result in
an increase in capillary density (Murray et al., 1979;
Tomanek et al., 1999a), indicating a strict control of vessel
density and, presumably, the molecular cues that govern
their formation. Direct experimental evidence that bio-
physical factors, for example, act via FGF in the developing
myocardium to pattern the nascent coronary capillary
network is lacking. Furthermore, interpretation would be
confounded by the fact that biomechanical forces acting on
and by the myocardium itself can promote expression of
growth factors by myocytes (Schneider et al., 1992; Zheng
et al., 2001) or release following physical damage (Clarke et
al., 1993, 1995; Kardami et al., 1991; Kaye et al., 1996a).
FGFs act in a paracrine manner, signaling through their
high-affinity receptors (Okada-Ban et al., 2000). In addition,
FGFs have been shown to up-regulate FGFR-1 mRNA in
mouse mammary tumor cells (Saito et al., 1991) and a
pancreatic cell line (Estival et al., 1996) and can also up-
regulate VEGFR-2 (Pepper and Mandriota, 1998). In this
study, we found that epicardial and subepicardial cells
adjacent to myocardium over-expressing FGF up-regulated
FGFR-1 and VEGFR-2, consistent with previous reports on
the biological activity of FGF. As the expressions of both
FGFR-1 and VEGFR-2 are up-regulated in a population of
cells that contain coronary precursors, we are given some clueas to the mechanism of action of the paracrine signal involved
in coronary induction and this may include signaling through
more than one pathway. The precise relationship of the
molecular pathways involved in this paracrine interaction
involving myocardium-derived signals and epicardium-
derived coronary precursors, however, remains to be eluci-
dated. Retroviral targeting to modulate specific factors in
coronary precursors may better define the role various
receptors and signaling pathways could play in the paracrine
induction and patterning of the capillary network.
We have begun to address the role the transmural
gradient of myocardium-derived FGF ligands may play in
acting as a template for the developing coronary vascula-
ture. Future work on elucidating the mechanism(s) by which
FGFs are regulated in the myocardium, and how this affects
the early stages of coronary development, will prove to be
an important step toward understanding how the coronary
vasculature forms and may provide an avenue for ther-
apeutic intervention in clinical situations.Acknowledgments
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